STABLE LIQUID FORMULATIONS
PE0017242026A1Pending Publication Date: 2026-08-31NOVO NORDISK AS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PE2026001857
- Authority / Receiving Office
- PE · PE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-13
- Filing Date
- 2024-12-13
- Publication Date
- 2026-08-31
Abstract
This refers to liquid formulations that include combinations of excipients and the medical uses of such formulations in humans. The liquid formulation comprises: a) an anti-transthyretin antibody, b) a buffer, c) a sugar, d) L-arginine, e) L-methionine, and f) a surfactant, and where the pH of the formulation is within the range of 5.0–7.0.
Need to check novelty before this filing date? Find Prior Art